| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00871442 Details | 2015-11-18 Interventional | 3 | 0 | Anesthetics Bupivacaine Fentanyl Labor Pain | would not substantially add to existing contributions in the literature - | |||
| NCT02023047 Details | 2015-11-17 Interventional | 1/2 | 33 | Nifedipine Fissure in Ano Anal Fissure | Met primary endpoint - | |||
| NCT01549847 Details | 2015-11-17 Interventional | 3 | 0 | Piracetam Muscle Weakness Myalgia Postpoliomyelit… Syndrome | Study was not approved by Health Surveillance Agency - | |||
| NCT01527097 Details | 2015-11-17 Interventional | 3 | 0 | Atorvastatin Psoriasis | We strongly feel that the ability to recruit the required number of patients is very low and
thus decided to stop the study. - | |||
| NCT01211691 Details | 2015-11-17 Interventional | 1/2 | - | Antibodies Antibodies, Mon… Hematologic Neo… Myelodysplastic… Neoplasms Preleukemia Primary Myelofi… Syndrome Myelodysplastic… Myelofibrosis (… | KaloBios to Wind Down Operations - | |||
| NCT01050933 Details | 2015-11-17 Interventional | 1 | 10 | Carbon Monoxide Healthy | resident left and no one to take over - | |||
| NCT01050712 Details | 2015-11-17 Interventional | 2 | 3 | Carbon Monoxide Ileus | According to retired PI, resident graduated and next resident never carried it to fruition. - | |||
| NCT01878136 Details | 2015-11-11 Interventional | 1/2 | 0 | Plasminogen Tissue Plasmino… Aneurysm Hemorrhage Hydrocephalus Intracranial An… Subarachnoid He… Vasospasm, Intr… Cerebral Aneury… Cerebral Vasosp… | Time constraints - | |||
| NCT01076556 Details | 2015-11-11 Interventional | 1 | 9 | Alvocidib Antibodies Antibodies, Mon… Antineoplastic … Cyclophosphamid… Immunoglobulins Rituximab Leukemia Leukemia, Lymph… Leukemia, Lymph… Leukemia, Proly… Lymphoma Chronic Lymphoc… Prolymphocytic … Recurrent Small… Refractory Chro… Stage I Chronic… Stage I Small L… Stage II Chroni… Stage II Small … Stage III Chron… Stage III Small… Stage IV Chroni… Stage IV Small … | - - | |||
| NCT00838578 Details | 2015-11-11 Interventional | 1/2 | 65 | Irinotecan Colorectal Neop… Colorectal Canc… | Per protocol, the study was terminated based on interim analysis results - | |||
| NCT01458639 Details | 2015-11-10 Interventional | 3 | 18 | Xenon Embolism Pulmonary Embol… | Decision to change trial design. PE adjudication by Independent Committee for final clinical diagnosis and blinded readings of Xe-133 and Technegas Ventilation and Tc-99m MAA Perfusion images were not performed due to early trial termination. No efficacy data available. | |||
| NCT00533390 Details | 2015-11-10 Interventional | 4 | 130 | Efavirenz Tuberculosis HIV Infections | Lack of financial support and low inclusion rate - | |||
| NCT01497197 Details | 2015-11-09 Interventional | 3 | 174 | Chorionic Gonad… Infertility Fertility Follicle Stimul… | Study was terminated as per sponsor's decision Study was terminated as per sponsor's decision. | |||
| NCT02599090 Details | 2015-11-06 Interventional | 2 | 0 | Sorafenib Temozolomide Glioblastoma Gliosarcoma | Multi phase study did not progress to Phase II. Phase I registered as NCT00734526. - | |||
| NCT01348126 Details | 2015-11-05 Interventional | 2/3 | 385 | Docetaxel Carcinoma, Non-… Lung Neoplasms Non-small Cell … Non-small Cell … Non-small Cell … | - - | |||
| NCT01032915 2009-014835-19 Details | 2015-11-05 Interventional | 3 | 125 | Antibodies, Mon… Uveitis Non-infectious … | Results of a planned interim analysis did not show significant effects for any of the 3 AIN
dose regimens versus placebo on any primary or secondary endpoint - | |||
| NCT01425970 Details | 2015-11-04 Interventional | 2 | 210 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Ribavirin Hepatitis Hepatitis C | Termination of study was due to safety reasons - | |||
| NCT01256489 Details | 2015-11-04 Interventional | 1/2 | 0 | Infliximab Blindness Stevens-Johnson… Syndrome Corneal Blindne… | Steven Johnson's Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are rare (~3 in
1 million). No eligible subjects have been identified. - | |||
| NCT01056757 Details | 2015-11-04 Interventional | 1/2 | 4 | Ribavirin Breast Neoplasm… Metastatic Brea… | Study closed because of new overlapping study with ribavirin. - | |||
| NCT00763893 2006-006112-30 Details | 2015-11-04 Interventional | 3 | [2 Refs] | 303 | Losartan Arachnodactyly Marfan Syndrome Syndrome | A similar publication has been released, suggesting a beneficial effect of sartans, and only 15
patients remained to be seen for their visit at 36 months. - |